RxDoctor Payments Data

Cornelius Meadows, MD

Family Medicine · Birmingham, ALNPI 1669467288

Payments from drug & device makers

$11,446in general payments, 2019–2025

Across 773 payments — averaging $14.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Novo Nordisk$1K
  • AbbVie$1K
  • Bayer$840
  • Lilly USA, LLC$720
  • Abbott$659
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$11,446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,446 in reported general payments places this provider in the 90th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$77,958
Medicare patients
261
Services billed
5,706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$150,692
MounjaroTirzepatide43$46,822
XareltoRivaroxaban33$27,510
EliquisApixaban28$26,400
JardianceEmpagliflozin31$25,371
MyrbetriqMirabegron29$16,753
LinzessLinaclotide14$13,879
JanuviaSitagliptin Phosphate12$8,825
Breo ElliptaFluticasone/Vilanterol17$6,818
Atorvastatin Calcium431$5,266
Rosuvastatin Calcium153$4,313
Levothyroxine Sodium306$3,751
Gabapentin188$3,677
Esomeprazole Magnesium62$3,477
Tresiba Flextouch U-100Insulin Degludec13$2,840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,425$150,692139 claims
Lilly USA, LLCMounjaro$720$46,82243 claims
Johnson & JohnsonXarelto$166$27,51033 claims
PfizerEliquis$2,133$26,40028 claims
Boehringer IngelheimJardiance$412$25,37131 claims
Astellas Pharma US IncMyrbetriq$66$16,75329 claims
AbbVieLinzess$1,101$13,87914 claims
MerckJanuvia$204$8,82512 claims
GSKBreo Ellipta$433$6,81817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →